Intranasal "painless" human Nerve Growth Factor [corrected] slows amyloid neurodegeneration and prevents memory deficits in App X PS1 mice.
Nerve Growth Factor (NGF) is being considered as a therapeutic candidate for Alzheimer's disease (AD) treatment but the clinical application is hindered by its potent pro-nociceptive activity. Thus, to reduce systemic exposure that would induce pain, in recent clinical studies NGF was administe...
Guardado en:
Autores principales: | Simona Capsoni, Sara Marinelli, Marcello Ceci, Domenico Vignone, Gianluca Amato, Francesca Malerba, Francesca Paoletti, Giovanni Meli, Alessandro Viegi, Flaminia Pavone, Antonino Cattaneo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6371b3f5cb36497fa8a94acd6e691d60 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sevoflurane Promotes Neurodegeneration Through Inflammasome Formation in APP/PS1 Mice
por: Guohua Li, et al.
Publicado: (2021) -
Single cycle structure-based humanization of an anti-nerve growth factor therapeutic antibody.
por: Sonia Covaceuszach, et al.
Publicado: (2012) -
Designing PCR Primers Painlessly
por: Morgan Feeney, et al.
Publicado: (2014) -
Evaluation of Painless Labor with Entonox Gas
por: H Pasha, et al.
Publicado: (2012) -
Research progress of bionic painless injection needle
por: Pan PAN, et al.
Publicado: (2021)